Clinical Trials in California

Showing 11181-11200 of 11,359 trials

Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer

NCT00054886

The primary goal of the study is to evaluate the effectiveness and safety of SU-011,248 as a treatment for metastatic kidney cancer.

Kidney Neoplasms

Pfizer63 participantsStarted Jan 2003

Los Angeles, California, United States • Mission Hills, California, United States • Monterey Park, California, United States +12 more locations

COMPLETEDPhase 2108 miles

A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer

NCT00034827

CI-1040 is an experimental drug that is being tested in patients who have advanced colorectal and lung cancer who failed no more than one prior chemotherapy regimen, breast cancer who have failed no more than 2 prior regimens and in patients with pancreatic cancer who have received no prior chemotherapy. CI-1040 is taken orally twice daily with meals. Patients are required to have blood tests periodically while receiving treatment and will be monitored closely throughout the trial for possible side effects and for response.

Colorectal NeoplasmsBreast NeoplasmsCarcinoma, Non-Small-Cell Lung+1 more

Pfizer172 participantsStarted Jan 2002

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Blendora, California, United States +27 more locations

Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer

A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer

Find Trials by Condition in California

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency

A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation

A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon

Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia

Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High Risk

Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer

Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes

A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents

Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's Disease

Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults

Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)

The Effects of the MME Procedure on Chronic Low Back Pain

A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent